Protagonist Therapeutics Inc.
PTGX | NASDAQ
$146.06
+$1.08 (+0.74%)
Sep 22, 2026, 11:01 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 166.63M | 3.78M | 85.77M | -39.34M | -34.77M | -11.66M | 131.67M | -33.21M | -30.62M | 207.34M | 27.34M | -34.11M | -38.46M | -33.73M | -34.19M | -31.23M | -41.04M | -20.93M | -36.91M | -33.8M | -30.84M | -24M |
Depreciation & Amortization | 804K | 407K | -904K | 361K | 304K | 239K | 536K | 647K | 1.48M | 236K | 832K | 827K | 821K | 832K | 840K | 853K | 843K | 833K | 819K | 704K | 628K | 624K |
Stock-Based Compensation | 28.56M | 14.52M | 10.7M | 10.56M | 10.91M | 13.8M | 9.09M | 10.17M | 8.94M | 9.35M | 6.6M | 6.77M | 8.34M | 7.58M | 5.51M | 5.95M | 6.81M | 5.94M | 5.02M | 4.78M | 3.94M | 2.66M |
Other Working Capital | -9.5M | -16.52M | -2.82M | 26.23M | -4.79M | -41.55M | -1.29M | -2.32M | -8.74M | 43.89M | -5.86M | 4.07M | 3.47M | -8.36M | -1.89M | -6.58M | 594K | -5.84M | 2.57M | 11.52M | 899K | -9.82M |
Other Non-Cash Items | -1.19M | -588K | -129.87M | -1.58M | -1.35M | -1.72M | -2.76M | -2.84M | -2.25M | -1.03M | -1.35M | -1.01M | -960K | -1.06M | -914K | -89K | 96K | 358K | 509K | 500K | 473K | 348K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -24.69M | -67.06M | -2.67M | 28.06M | -3.88M | 124.69M | -167.72M | -2.63M | 291.06M | -243.33M | -16.46M | 908K | 4.02M | -7.98M | -2.88M | -683K | 19.66M | -23.86M | 3.62M | -645K | 2.11M | -8.39M |
Operating Cash Flow | 170.11M | -48.94M | -36.98M | -1.94M | -28.78M | 125.36M | -29.18M | -27.86M | 268.62M | -27.43M | 16.96M | -26.61M | -26.24M | -34.35M | -31.64M | -25.2M | -13.64M | -37.67M | -26.94M | -28.47M | -23.7M | -28.76M |
Capital Expenditures | -383K | -215K | 1.45M | -88K | -813K | -545K | -310K | -775K | -28K | -242K | -19K | -404K | -176K | -10K | -70K | -162K | -290K | -273K | -196K | -265K | -500K | -140K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25.94M | -9.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -203.64M | -68.97M | 442.31M | -161.12M | -67.15M | -214.04M | -114.41M | -266.67M | -174.96M | -65.67M | -97.97M | -58.96M | -6.06M | -28.06M | -80.6M | -32.16M | -46.29M | -55.83M | -30.69M | -92.44M | -76.26M | -87.21M |
Sales Maturities Of Investments | 292.49M | 160.08M | -345.62M | 102.65M | 122.78M | 120.18M | 105.99M | 58.73M | 86.87M | 71.98M | 36.7M | 45.8M | 32M | 37.9M | 84.6M | 89.6M | 81.31M | 51.63M | 58.75M | 48M | 84.53M | 80.55M |
Other Investing Acitivies | n/a | n/a | -49.32M | n/a | -5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 25.94M | 9.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 88.46M | 90.89M | 48.82M | -58.56M | 54.81M | -94.4M | -8.73M | -208.71M | -88.12M | 6.07M | -61.29M | -13.56M | 25.76M | 9.83M | 3.94M | 57.28M | 34.73M | -4.48M | 27.87M | -44.71M | 7.77M | -6.79M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | -479K | n/a | n/a | n/a | -600K | 519K | 35.39M | 304K | 2.16M | n/a | -2K | n/a | 2.37M | 2.34M | n/a | 1.4M | -189K |
Financial Cash Flow | 33.12M | 23.37M | 2.84M | 5.66M | 2.93M | 11.44M | 4.03M | 12.05M | 2.57M | 7.2M | 527K | 35.32M | 108.17M | 26.46M | 553K | 680K | 680K | 16.93M | 2.17M | 1.38M | 125.39M | 979K |
Net Cash Flow | 291.69M | 65.32M | 14.68M | -54.83M | 28.96M | 42.4M | -33.87M | -224.52M | 183.08M | -14.16M | -43.8M | -4.86M | 107.7M | 1.94M | -27.07M | 32.58M | 21.76M | -25.19M | 3.12M | -71.87M | 109.41M | -34.37M |
Free Cash Flow | 169.73M | -49.16M | -35.53M | -2.03M | -29.59M | 124.82M | -29.49M | -28.64M | 268.59M | -27.67M | 16.94M | -27.02M | -26.41M | -34.36M | -31.71M | -25.36M | -13.93M | -37.94M | -27.14M | -28.74M | -24.2M | -28.9M |
Adj. Free Cash Flow | 141.17M | -63.68M | -46.23M | -12.58M | -40.51M | 111.02M | -38.58M | -38.8M | 259.65M | -37.02M | 10.34M | -33.78M | -34.76M | -41.94M | -37.22M | -31.31M | -20.73M | -43.87M | -32.16M | -33.51M | -28.14M | -31.56M |
Maintenance CapEx | -383K | -215K | 1.45M | -84.92K | -698.07K | -545K | n/a | -458.97K | n/a | n/a | n/a | -404K | -176K | -10K | -70K | -162K | -290K | n/a | n/a | -265K | -500K | n/a |
Growth CapEx | n/a | n/a | n/a | -3.08K | -114.93K | n/a | -310K | -316.03K | -28K | -242K | -19K | n/a | n/a | n/a | n/a | n/a | n/a | -273K | -196K | n/a | n/a | -140K |
Owner Earnings | 169.73M | -49.16M | -35.53M | -2.02M | -29.48M | 124.82M | -29.18M | -28.32M | 268.62M | -27.43M | 16.96M | -27.02M | -26.41M | -34.36M | -31.71M | -25.36M | -13.93M | -37.67M | -26.94M | -28.74M | -24.2M | -28.76M |
Add to Watchlist
Select watchlists to add or remove PTGX